Jason Lau

Array ( [id] => 8866863 [patent_doc_number] => 20130150566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'TUMOR-TARGETED TNF-RELATED APOPTOSIS-INDUCING LIGAND\'S VARIANT AND THE APPLICATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/503771 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9639 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7509981 [patent_doc_number] => 20110256145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Connective Tissue Growth Factor-3 (CTGF-3)' [patent_app_type] => utility [patent_app_number] => 13/172664 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20905 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256145.pdf [firstpage_image] =>[orig_patent_app_number] => 13172664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582238 [patent_doc_number] => 08772241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Peptide and use thereof' [patent_app_type] => utility [patent_app_number] => 13/701465 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7890 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663617 [patent_doc_number] => 20110312886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'TGF-ß AND METHODS OF TREATING OCULAR AND OTHER DISEASES' [patent_app_type] => utility [patent_app_number] => 13/158582 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3759 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312886.pdf [firstpage_image] =>[orig_patent_app_number] => 13158582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854137 [patent_doc_number] => 20130143812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'ANTI-INFLAMMATORY DRUG' [patent_app_type] => utility [patent_app_number] => 13/699839 [patent_app_country] => US [patent_app_date] => 2011-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5461 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579747 [patent_doc_number] => 20110293630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Antibodies to Human GDF8' [patent_app_type] => utility [patent_app_number] => 13/115170 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21010 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293630.pdf [firstpage_image] =>[orig_patent_app_number] => 13115170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560821 [patent_doc_number] => 20110274653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'DENDRITIC CELL IMMUNORECEPTORS (DCIR)-MEDIATED CROSSPRIMING OF HUMAN CD8+ T CELLS' [patent_app_type] => utility [patent_app_number] => 13/100684 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 21466 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274653.pdf [firstpage_image] =>[orig_patent_app_number] => 13100684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710271 [patent_doc_number] => 20120003244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'METHODS FOR APCDD1 MEDIATED REGULATION OF HAIR GROWTH AND PIGMENTATION AND MUTANTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/099044 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 63170 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13099044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10641472 [patent_doc_number] => 09358323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-07 [patent_title] => 'Flowable ceramic putty' [patent_app_type] => utility [patent_app_number] => 13/695109 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7103 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8791662 [patent_doc_number] => 20130108631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'METHODS FOR DETECTING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/642874 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18281 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062996 [patent_doc_number] => 20110200990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'RECEPTOR ACTIVATOR OF NF kappa-B' [patent_app_type] => utility [patent_app_number] => 13/092718 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16438 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200990.pdf [firstpage_image] =>[orig_patent_app_number] => 13092718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842593 [patent_doc_number] => 20130138221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'METHODS AND COMPOSITIONS FOR IMPROVING IMPLANT OSSEOINTEGRATION' [patent_app_type] => utility [patent_app_number] => 13/641506 [patent_app_country] => US [patent_app_date] => 2011-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9995 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9476748 [patent_doc_number] => 20140134211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'Formulations and Methods for Recovery From Dental Surgery' [patent_app_type] => utility [patent_app_number] => 13/082806 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4979 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13082806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950116 [patent_doc_number] => 20130195896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF A NEOPLASIA' [patent_app_type] => utility [patent_app_number] => 13/639815 [patent_app_country] => US [patent_app_date] => 2011-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 23293 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484205 [patent_doc_number] => 20110250130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'TNF-ALPHA BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/081212 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34112 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250130.pdf [firstpage_image] =>[orig_patent_app_number] => 13081212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511383 [patent_doc_number] => 20110257093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'THERAPIES FOR ACUTE RENAL FAILURE' [patent_app_type] => utility [patent_app_number] => 13/079161 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9620 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257093.pdf [firstpage_image] =>[orig_patent_app_number] => 13079161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669084 [patent_doc_number] => 20110318353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Humanized IL-25 Antibodies' [patent_app_type] => utility [patent_app_number] => 13/075241 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18961 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13075241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8385687 [patent_doc_number] => 08263079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Antibodies against CSF-1R' [patent_app_type] => utility [patent_app_number] => 13/073004 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22470 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13073004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490120 [patent_doc_number] => 20110237513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 13/072241 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 34248 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237513.pdf [firstpage_image] =>[orig_patent_app_number] => 13072241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10892913 [patent_doc_number] => 08916525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'TNF-A and TWEAK dual antagonist for the prophylaxis and treatment of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 13/635868 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 15182 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635868 [rel_patent_id] =>[rel_patent_doc_number] =>)